AlgaHealth

AlgaHealth, established in Israel in 2017, operates in the biotechnology sector, focusing on the development and production of high-value functional ingredients from microalgae. The company was co-founded by Hagay Tzur and Dr. Oran Ayalon, who brought extensive experience in the microalgae industry and biotech R&D, respectively. Dr. Ayalon, the CTO, holds a PhD in biology and chemistry from the Weizmann Institute of Science and has over two decades of R&D experience, including leadership roles at Algatechnologies and Algalo. The management team also includes CEO Eran Itzkovitch, who has 20 years of executive experience, and COO Itai Ivry, with 30 years of experience in designing microalgae production facilities.

The company's core business involves producing biologically active compounds, particularly fucoxanthin, a natural antioxidant aimed at preventing conditions like obesity, diabetes, and cardiovascular diseases. AlgaHealth employs a B2B model, supplying its ingredients to manufacturers in the nutraceutical, food, and cosmetics industries. The firm's production process is designed to be more sustainable and cost-effective than traditional methods that rely on harvesting seaweed. By cultivating specific microalgae strains in controlled, land-based facilities, AlgaHealth achieves a fucoxanthin concentration that can be up to 100 times higher than that found in seaweed, while avoiding the environmental damage associated with macroalgae harvesting. This method also eliminates the need for organic solvents in the extraction process.

AlgaHealth's product line includes NutriXanthin™ for food supplements and DermaXanthin™ for cosmetics, both containing high concentrations of fucoxanthin. The company leverages a three-pillar technological approach: advanced biotechnology for non-GMO strain development (including CRISPR techniques), patented cultivation methods to increase efficiency, and an AI-based production process that uses machine learning for real-time control and yield optimization. Future plans involve extracting other valuable compounds like polysaccharides for skincare and developing additional ingredients for various industries. The company is a portfolio company of the Trendlines Agtech Incubator and has received funding from investors including the European Union and MassChallenge. Keywords: microalgae, fucoxanthin, nutraceutical ingredients, cosmetic ingredients, biotechnology, B2B, sustainable production, natural antioxidants, metabolic syndrome, food supplements, skincare, agtech, strain development, AI-based manufacturing, green technology, bioproduction, specialty chemicals, functional foods, AlgaHealth, Dr. Oran Ayalon